Clinical trial
A Prospective, Open, Non-comparative, Post-market Clinical Follow-up Investigation to Confirm Safety and Performance of Avance Solo NPWT System in Low to Moderate Exuding Acute (Traumatic Wounds and Flaps and Grafts), as Well as Subacute (e.g., Dehisced Wounds) Wounds
NCT04754048 is registered in ClinicalTrials.gov with Molnlycke Health Care AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open, Non-comparative, Post-market Clinical Follow-up Investigation to Confirm Safety and Performance of Avance Solo NPWT System in Low to Moderate Exuding Acute (Traumatic Wounds and Flaps and Grafts), as Well as Subacute (e.g., Dehisced Wounds) Wounds
- Lead sponsor
- Molnlycke Health Care AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 15, 2021
- Completion date
- December 6, 2022
- Enrollment
- 105 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
acute wound, dehiscence, skin flap, skin graft, subacute wound, traumatic wound